ArticleClinical pharmacokinetics2021

Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma.

Ken Ogasawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.